Shox2.2

General

Cell Line

hPSCreg name MRIi024-A
Cite as:
MRIi024-A (RRID:CVCL_A0SZ)
Alternative name(s)
Shox2.2
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines
MRIi016-A-1
(SHOX2 c.*28T>C_isoWT)
Donor diseases:
Atrial Fibrillation
MRIi016-A
(Shox2.1)
Donor diseases:
Atrial Fibrillation
GRCHJUi001-A
(LYJ-iPS-C)
Donor diseases:
Atrial Fibrillation
ESi108-A
(AFib-C53)
Donor diseases:
Atrial Fibrillation
UKKi030-A
(NP0134-6D)
Donor's gene variants:
SCN5A
Donor diseases:
Brugada syndrome
UKKi030-B
(NP0134-18A)
Donor's gene variants:
SCN5A
Donor diseases:
Brugada syndrome
UKKi030-C
(NP0134-26B)
Donor's gene variants:
SCN5A
Donor diseases:
Brugada syndrome
UKKi024-A
(NP0133-5)
Donor diseases:
Brugada syndrome
UKKi024-B
(NP0133-1)
Donor diseases:
Brugada syndrome
UKKi024-C
(NP0133-4)
Donor diseases:
Brugada syndrome
UKKi035-A
(NP0139-A, NP0139-3E)
Donor's gene variants:
MYBPC3, MYBPC3
Donor diseases:
Rare hypertrophic cardiomyopathy
UKKi035-B
(NP0139-B, NP0139-6C)
Donor's gene variants:
MYBPC3, MYBPC3
Donor diseases:
Rare hypertrophic cardiomyopathy
UKKi035-C
(NP0139-C, NP0139-24D)
Donor's gene variants:
MYBPC3, MYBPC3
Donor diseases:
Rare hypertrophic cardiomyopathy
FAMRCi009-A
(RCMP43)
Donor's gene variants:
FLNC
Donor diseases:
Restrictive Cardiomyopathy
FAMRCi011-A
(ARVC51)
Donor's gene variants:
FLNC
Donor diseases:
Inherited arrhythmogenic cardiomyopathy
YCMi009-A
(YCMi009-hDCM009-A)
Donor diseases:
dilated cardiomyopathy
ICGi028-A
(HCM4fm5.2)
Donor diseases:
Hypertrophic Cardiomyopathy
IBBISTi005-A
(F81 (940) clone 5)
Donor diseases:
Hypertrophic Cardiomyopathy
IBBISTi005-B
(F81 (940) clone 8)
Donor diseases:
Hypertrophic Cardiomyopathy
FAMRCi011-B
(ARVC51b)
Donor's gene variants:
FLNC
Donor diseases:
Inherited arrhythmogenic cardiomyopathy
IBBISTi007-A
(6F26)
Donor's gene variants:
MYBPC3
Donor diseases:
Hypertrophic Cardiomyopathy
IBBISTi007-B
(2F26)
Donor's gene variants:
MYBPC3
Donor diseases:
Hypertrophic Cardiomyopathy
SCVIi096-A
(SCVI-675fs1)
Donor diseases:
Hypertrophic Cardiomyopathy
SCVIi097-A
(SCVI-675fs2)
Donor diseases:
Hypertrophic Cardiomyopathy
SCVIi098-A
(SCVI-675fs3)
Donor diseases:
Hypertrophic Cardiomyopathy
SCVIi099-A
(SCVI-675fs4)
Donor diseases:
Hypertrophic Cardiomyopathy
CCMi012-A
(LMNA_SP_C3)
Donor diseases:
Dilated Cardiomyopathy
SCVIi050-A
(SCVI2486)
Donor diseases:
Dilated Cardiomyopathy
BRCi021-A
(TUH1)
Donor diseases:
Cardiomyopathy
ISMMSi044-A
(PLNR14del-1BC1)
Donor diseases:
Cardiomyopathy
ISMMSi045-A
(PLNR14del-2BC4)
Donor diseases:
Cardiomyopathy
ISMMSi047-A
(PLN-R14del-4AC4)
Donor diseases:
Cardiomyopathy
ISMMSi048-A
(PLN-R14del-5BC4)
Donor diseases:
Cardiomyopathy
SCVIi037-A
(SCVI672)
Donor diseases:
hypertrophic cardiomyopathy
ITXi003-A
(MS368)
Donor diseases:
Long QT Syndrome
Last update 20th April 2022
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator Klinikum rechts der Isar (MRI)

External Databases

BioSamples SAMEA9466941
Cellosaurus CVCL_A0SZ
Wikidata Q108820973

General Information

Publications
* Is the cell line readily obtainable for third parties?
Yes
Research use: allowed
Clinical use: not allowed
Commercial use: not allowed

Donor Information

General Donor Information

Sex male
Ethnicity caucasien

Phenotype and Disease related information (Donor)

Diseases A disease was diagnosed.
Synonyms
  • AFib
  • AF
  • Atrial fibrillation
  • Atrial Fibrillation
show more synonyms

Karyotyping (Donor)

Has the donor karyotype been analysed?
Unknown

External Databases (Donor)

BioSamples SAMEA9466942

Ethics

Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? Yes
Was the consent voluntarily given? Yes
Has the donor been informed that participation will not directly influence their personal treatment? Yes
Can you provide us with a copy of the Donor Information Sheet provided to the donor? Yes
Do you (Depositor/Provider) hold the original Donor Consent Form? No
If you do not hold the Donor Consent Form, do you know who does? Yes
Please provide the contact information http://www.klinikum.uni-muenchen.de/Muenchener-Zentrum-fuer-Seltene-Erkrankungen/de/Team-_-Kontakt/Kaeaeb/index.html
Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. pseudonymised
Does consent explicitly allow the derivation of pluripotent stem cells? Yes
Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? No
How may genetic information associated with the cell line be accessed? Controlled Access
Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? No
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? Yes
Name of accrediting authority involved? Ethikkommission, Fakulät für Medizin, Klinikum rechts der Isar (TUM)
Approval number 2109/08, Teilprojekt 5
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used?

hIPSC Derivation

General

Source cell type
A peripheral blood cell with a single nucleus. This category includes lymphocytes and monocytes.
Synonyms
  • PERIPHERAL BLOOD MONONUCLEAR CELL
  • Peripheral Blood Mononuclear Cell
  • PBMC
Source cell origin
A liquid tissue; its major function is to transport oxygen throughout the body. It also supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection. Several hormones also travel in the blood.
Synonyms
  • Reticuloendothelial System, Blood
  • Peripheral Blood
  • peripheral blood
  • blood
  • Blood
  • Whole Blood
  • BLOOD
  • portion of blood
  • vertebrate blood
show more synonyms

Reprogramming method

Vector type Non-integrating
Vector Sendai virus
Is reprogramming vector detectable?
No
Methods used
RT-PCR
Files and images showing reprogramming vector expressed or silenced

Vector free reprogramming

Other

Derived under xeno-free conditions
Unknown
Derived under GMP?
Unknown
Available as clinical grade?
Unknown

Culture Conditions

Surface coating Matrigel/Geltrex
Feeder cells
No
Passage method Enzymatically
Dispase
CO2 Concentration 5 %
Medium Essential 8™
Supplements
Penicillin/Streptomycin 5 ml
E8 supplement 10 ml
Has Rock inhibitor (Y27632) been used at passage previously with this cell line?
No
Has Rock inhibitor (Y27632) been used at cryo previously with this cell line?
No
Has Rock inhibitor (Y27632) been used at thaw previously with this cell line?
No

Characterisation

Analysis of Undifferentiated Cells
Marker Expressed Immunostaining RT-PCR Flow Cytometry Enzymatic Assay Expression Profiles
TRA 1-81
Yes
NANOG
Yes
Differentiation Potency
Endoderm
Ont Id: UBERON_0000925
In vitro spontaneous differentiation
Marker Expressed
SOX7 SRY-box transcription factor 7
Unknown
Protocol or reference
Mesoderm
Ont Id: UBERON_0000926
In vitro spontaneous differentiation
Protocol or reference
Ectoderm
Ont Id: UBERON_0000924
In vitro spontaneous differentiation
Marker Expressed
KRT14 keratin 14
Unknown
Protocol or reference

Genotyping

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
Unknown

Other Genotyping (Cell Line)